Immunovant
Brian Goetz possesses extensive experience in the pharmaceutical industry, focusing on medical science and liaison roles. Currently serving as the Director of Medical Science Liaison at Immunovant, Brian has previously held senior positions at Biogen, including Director of Medical Excellence - Digital and Senior Medical Science Liaison. Other significant roles include Director of Medical Science Liaisons & Managed Care Liaisons at Stealth BioTherapeutics, and various positions at Novartis, culminating in Director of Content Development & Training. Brian holds a Doctor of Pharmacy (PharmD) from the University of Maryland, Baltimore, and a Bachelor of Science in Pharmacy from Duquesne University.
This person is not in any teams
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.